LICENSE AGREEMENTS (Details) - USD ($) $ in Millions	1 Months Ended						12 Months Ended
	May 31, 2025	Apr. 30, 2024	Feb. 28, 2023	Jan. 31, 2022	Dec. 31, 2020	Aug. 31, 2017	Jun. 30, 2025
XOMA (US) LLC | Xoma License Agreement | After Clinical and Regulatory Milestones | Maximum
License Agreements
Maximum amount of milestone events							$ 185.0
XOMA (US) LLC | US Clinical Trial Rz358 (ersodetug) | Xoma License Agreement | Upon Regulatory Approval
License Agreements
Milestone closing payment							25.0
XOMA (US) LLC | Phase 2 Clinical Trial RZ358 (ersodetug) | Xoma License Agreement
License Agreements
Milestone closing payment				$ 2.0
XOMA (US) LLC | Phase 3 Clinical Trial RZ 358 (ersodetug) | Xoma License Agreement
License Agreements
Milestone closing payment	$ 5.0	$ 5.0
XOMA (US) LLC | Phase 3 Clinical Trial RZ 358 (ersodetug) | Xoma License Agreement | Upon Regulatory Approval
License Agreements
Milestone closing payment							25.0
ActiveSite Pharmaceuticals, Inc | Clinical Trial Rz 402 | Development And License Agreement
License Agreements
Royalties percentage						2.00%
ActiveSite Pharmaceuticals, Inc | Clinical Trial Rz 402 | Development And License Agreement | Scenario, Plan | Maximum
License Agreements
Maximum amount of milestone events						$ 46.5
ActiveSite Pharmaceuticals, Inc | Phase 1 Clinical Trial RZ402 | Development And License Agreement
License Agreements
Milestone closing payment					$ 1.0
ActiveSite Pharmaceuticals, Inc | Phase 2 Clinical Trial RZ402 | Development And License Agreement
License Agreements
Milestone closing payment			$ 3.0
ActiveSite Pharmaceuticals, Inc | Phase 3 Clinical Trial RZ 402 | Development And License Agreement | Scenario, Plan
License Agreements
Milestone closing payment							$ 5.0